Abstract
A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Current Pharmaceutical Analysis
Title: Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives
Volume: 4 Issue: 3
Author(s): Bo Yang, Yong Chen, Jun Lin and Yu Liu
Affiliation:
Keywords: 3-Tigloyl-azadirachtol, Azadirachtin B, %-Cyclodextrin, Inclusion complexation, Supra-molecular chemistry
Abstract: A series of β-cyclodextrin/3-tigloyl-azdirachtol inclusion complexes were prepared from β-cyclodextrin, heptakis( 2,3,6-tri-O-methyl)-β-cyclodextrin, mono(6-ethylene-diamino-6-deoxy)-β-cyclodextrin and mono(6-diethylenetriamino- 6-deoxy)-β-cyclodextrin with 3-tigloyl-azdirachtol (azadirachtin B, AZ-B) in ca. 90%, and their inclusion complexation behaviors were investigated by means of UV/Vis, 1H NMR and 2D NMR spectroscopy. The results showed that the AZ-B could be efficiently encapsulated in the cyclodextrin cavity in aqueous solution to produce complexes that were more stabilized than free AZ-B. Furthermore, the water solubility of AZ-B was obviously increased to high levels up to 4-6.3 mg/ml (calculated as AZ-B) after inclusion complexation with cyclodextrins. This satisfactory water solubility and high stability of the cyclodextrin – AZ-B complexes will be potentially useful, for their application as biopesticide and herbal medicine or healthcare products. The enhanced binding ability of cyclodextrins toward AZ-B was discussed from the viewpoint of the size/shape – fit concept and multiple recognition mechanism between host and guest.
Export Options
About this article
Cite this article as:
Yang Bo, Chen Yong, Lin Jun and Liu Yu, Inclusion Complexation Behaviors of 3-Tigloyl-Azadirachtol with β-Cyclodextrin Derivatives, Current Pharmaceutical Analysis 2008; 4 (3) . https://dx.doi.org/10.2174/157341208785161272
DOI https://dx.doi.org/10.2174/157341208785161272 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Compounds Therapeutic Features in Brain Disorders by Experimental, Bioinformatics and Cheminformatics Methods
Current Medicinal Chemistry Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics
Recent Patents on Biotechnology Discovering New Schistosome Drug Targets: The Role of Transcriptomics
Current Drug Targets Current Update on Eosinophilic Lung Diseases and Anti-IL-5 Treatment
Recent Patents on Anti-Infective Drug Discovery Chemical and Bioactive Diversities of the Genus Chaetomium Secondary Metabolites
Mini-Reviews in Medicinal Chemistry Synthesis of Imidazo[1,2-b]pyridazine Comprised Piperazine, Morpholine Derivatives as Potent Antimycobacterial Agents with In Vivo Locomotor Activity
Anti-Infective Agents Current Bioactive Azole-Containing Natural Products
Current Bioactive Compounds Atranorin – An Interesting Lichen Secondary Metabolite
Mini-Reviews in Medicinal Chemistry Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
Current Medicinal Chemistry Sulfonamides as Potential Bioactive Scaffolds
Current Organic Chemistry Preparation and Antitubercular Activities of Palindromic Hydrazinecarbothioamides and Carbonothioic Dihydrazides
Letters in Drug Design & Discovery The Use of Fluorescence Polarization Assays for the Detection of Infectious Diseases
Combinatorial Chemistry & High Throughput Screening New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Functionally Engineered Nanosized Particles in Pharmaceutics: Improved Oral Delivery of Poorly Water-soluble Drugs
Current Pharmaceutical Design Biographical Sketches of Authors
Current Topics in Medicinal Chemistry Challenges and Persistent Questions in the Treatment of Trichomoniasis
Current Topics in Medicinal Chemistry Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Biologic Agents for Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Monoterpenoid Geraniol Improves Anti-mycobacterial Drug Efficiency by Interfering with Lipidome and Virulence of Mycobacteria
Infectious Disorders - Drug Targets